The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Identification of novel antimicrobials using a live-animal infection model
Open accessAbstract
The alarming increase of antibiotic-resistant bacterial pathogens points to the need for novel therapeutic approaches to combat infection. To discover novel antimicrobials, we devised a screen to identify compounds that promoted the survival of the model laboratory nematode Caenorhabditis elegans infected with the human opportunistic pathogen Enterococcus faecalis . E. faecalis colonizes the nematode intestinal tract, forming a persistent lethal infection. Infected nematodes were rescued by antibiotic treatment in a dose-dependent manner, and antibiotic treatment markedly reduced the number of bacteria colonizing the nematode intestine. To facilitate high throughput screening of compound libraries, we adapted a previously developed agar-based C. elegans - E. faecalis infection assay so that it could be carried out in liquid medium in standard 96-well microtiter plates. We used this simple infection system to screen 6,000 synthetic compounds and 1,136 natural product extracts. We identified 16 compounds and 9 extracts that promoted nematode survival. Some of the compounds and extracts inhibited E. faecalis growth in vitro , but, in contrast to traditional antibiotics, the in vivo effective dose of many of these compounds was significantly lower than the minimum inhibitory concentration needed to prevent the growth of E. faecalis in vitro . Moreover, many of the compounds and extracts had little or no affect on in vitro bacterial growth. Our findings indicate that the whole-animal C. elegans screen identifies not only traditional antibiotics, but also compounds that target bacterial virulence or stimulate host defense.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE GENETICS OF CAENORHABDITIS ELEGANS
Brenner, S. (1974) · Genetics · doi:10.1093/genetics/77.1.71 · Cited by 15,081
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
C. elegans: des neurones et des gènes
Gally, C., & Bessereau, J.-L. (2003) · médecine/sciences · doi:10.1051/medsci/20031967725 · Cited by 3,287
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Are innate immune signaling pathways in plants and animals conserved?
Ausubel, F. M. (2005) · Nature Immunology · doi:10.1038/ni1253 · Cited by 976
Self-citationA Conserved p38 MAP Kinase Pathway in Caenorhabditis elegans Innate Immunity
Kim, D. H., Feinbaum, R., Alloing, G., Emerson, F. E., Garsin, D. A., Inoue, H., Tanaka-Hino, M., Hisamoto, N., Matsumoto, K., Tan, M.-W., et al. (2002) · Science · doi:10.1126/science.1073759 · Cited by 853
Self-citationEfflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Where will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755
Caenorhabditis elegans : modern biological analysis of an organism
Epstein, H. F., & Diane, C. S. (1995) · Cited by 685
Antibiotics: Actions, Origins, Resistance
Walsh, C. T. (2003) · Medical Entomology and Zoology · Cited by 675
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
Lewis, J. A., & Fleming, J. T. (1995) · PubMed · Cited by 606
A simple model host for identifying Gram-positive virulence factors
Garsin, D. A., Sifri, C. D., Mylonakis, E., Qin, X., Singh, K. V., Murray, B. E., Calderwood, S. B., & Ausubel, F. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191378698 · Cited by 568
Self-citationIn vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
Sahm, D. F., Kissinger, J., Gilmore, M. S., Murray, P. R., Mulder, R., Solliday, J., & Clarke, B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1588 · Cited by 497
Chapter 1 Basic Culture Methods
Lewis, J. A., & Fleming, J. T. (1995) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61381-3 · Cited by 471
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
Schulz, M., & Schmoldt, A. (2003) · PubMed · Cited by 439
Qin, X., Singh, K. V., Weinstock, G. M., & Murray, B. E. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2579-2586.2000 · Cited by 364
Small-Molecule Inhibitor of Vibrio cholerae Virulence and Intestinal Colonization
Hung, D. T., Shakhnovich, E. A., Pierson, E., & Mekalanos, J. J. (2005) · Science · doi:10.1126/science.1116739 · Cited by 358
Characterization of a germ-line proliferation mutation in C. elegans
Beanan, M. J., & Strome, S. (1992) · Development · doi:10.1242/dev.116.3.755 · Cited by 308
The worm has turned – microbial virulence modeled in Caenorhabditis elegans
Sifri, C. D., Begun, J., & Ausubel, F. M. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.01.003 · Cited by 285
Self-citationBacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis
Huycke, M. M., Spiegel, C. A., & Gilmore, M. S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1626 · Cited by 283
Horrobin, D. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1012 · Cited by 248
Ciornei, C. D., Sigurdardóttir, T., Schmidtchen, A., & Bodelsson, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2845-2850.2005 · Cited by 247
Human Health Consequences of Antimicrobial Drug--Resistant Salmonella and Other Foodborne Pathogens
Angulo, F. J., & Molbak, K. (2005) · Clinical Infectious Diseases · doi:10.1086/497599 · Cited by 223
Murray, B. E., Singh, K. V., Ross, R. P., Heath, J. D., Dunny, G. M., & Weinstock, G. M. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.16.5216-5223.1993 · Cited by 205
Using the Nematode Caenorhabditis Elegans To Predict Mammalian Acute Lethality To Metallic Salts
Williams, P. L., & Dusenbery, D. B. (1988) · Toxicology and Industrial Health · doi:10.1177/074823378800400406 · Cited by 205
The nematode Caenorhabditis elegans as a model of organophosphate-induced mammalian neurotoxicity
Cole, R. D., Anderson, G. L., & Williams, P. L. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.09.013 · Cited by 168
Bioterrorism: A clear and present danger
Lane, H. C., Montagne, J. L., & Fauci, A. S. (2001) · Nature Medicine · doi:10.1038/nm1201-1271 · Cited by 166
Evolutionary perspectives on innate immunity from the study of Caenorhabditis elegans
Kim, D. H., & Ausubel, F. M. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.11.007 · Cited by 143
Self-citationTanaka‐Hino, M., Sagasti, A., Hisamoto, N., Kawasaki, M., Nakano, S., Ninomiya‐Tsuji, J., Bargmann, C. I., & Matsumoto, K. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf001 · Cited by 136
Tackling both sides of the host–pathogen equation with Caenorhabditis elegans
Ewbank, J. J. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(01)01531-3 · Cited by 130
Worms and Flies as Genetically Tractable Animal Models To Study Host-Pathogen Interactions
Mylonakis, E. E., & Aballay, A. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.3833-3841.2005 · Cited by 115
Cytotoxicity of Hydrogen Peroxide Produced by Enterococcus faecium
Moy, T. I., Mylonakis, E. E., Calderwood, S. B., & Ausubel, F. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4512-4520.2004 · Cited by 85
Self-citationResistance of Enterococcus faecium to neutrophil-mediated phagocytosis
Arduino, R. C., Jacques-Palaz, K. D., Murray, B. E., & Rakita, R. M. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5587-5594.1994 · Cited by 83
The search for new antimicrobials: why we need new options
Zinner, S. H. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.6.907 · Cited by 35
Cited by
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Self-citationTargeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
The Science of Antibiotic Discovery
Lewis, K. (2020) · Cell · doi:10.1016/j.cell.2020.02.056 · Cited by 797
Self-citationFiore, E., Van Tyne, D., & Gilmore, M. S. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0053-2018 · Cited by 503
Metadata
- Authors
- Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., & Ausubel, F. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-07-05
- Volume
- 103
- Issue
- 27
- Pages
- 10414-10419
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2060700236
- Cited by
- 294
- References
- 36
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.